Marcia Cruz Correa, MD
Gastroenterology · San Juan, PRNPI 1962497164
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $49,813 of the $62,369 with a category attached, or 79.9%. Beone Medicines USA, Inc. accounts for 70.9% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $49,338, more than ten times the $483 reported in 2019. Among gastroenterology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $944.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beone Medicines USA, Inc.$44K
- Janssen Research & Development, LLC$6K
- Genmab U.S., Inc.$5K
- Beigene USA, Inc.$2K
- Exact Sciences$2K
- AstraZeneca$849
- plus $1K from 14 others
Across 2,402 payments — averaging $5144.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3M
- E.r. Squibb & Sons, L.L.C.$2.8M
- Janssen Research & Development, LLC$2.1M
- Merck$1.8M
- Mirati Therapeutics, Inc.$919K
- Incyte Corporation$646K
- plus $1.2M from 13 others
What the payments were for
- Consulting fees$49,81380%
- Travel & lodging$10,62617%
- Food & beverage$1,8303%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beone Medicines USA, Inc. | 19 | $44,224 |
| Janssen Research & Development, LLC | 3 | $5,810 |
| Genmab U.S., Inc. | 5 | $5,323 |
| Beigene USA, Inc. | 3 | $2,426 |
| Exact Sciences | 4 | $2,275 |
| AstraZeneca | 3 | $849 |
| E.r. Squibb & Sons, L.L.C. | 4 | $235 |
| Merck | 6 | $146 |
| Macrogenics, Inc. | 2 | $141 |
| Johnson & Johnson | 4 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $120 |
| AbbVie | 1 | $116 |
| Johnson And Johnson International | 1 | $101 |
| Smith+Nephew | 2 | $100 |
| Exelixis Inc. | 1 | $100 |
| Olympus Latin America, Inc. | 1 | $99 |
| Taiho Oncology, Inc. | 1 | $62 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| PBG Puerto Rico LLC | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$62,369 in reported general payments places this provider in the 95th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 28 | $240 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Juan
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
- Hector LozanoSan Juan$28K
- Rafael Rodriguez LopezSan Juan$20K
- Alexis Gonzalez RiveraSan Juan$16K
- Sulimar Rodriguez SantiagoSan Juan$11K
- Esther TorresSan Juan$9K
- Yahaira Moreno DenizardSan Juan$9K
- Ricky Jimenez CarloSan Juan$8K
- Suzette Rivera MacmurraySan Juan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.